Evidence map›Paper›PMID 36602346›Full record

ArticleAntimicrobial agents and chemotherapy2023

Molecular Characteristics of an NDM-4 and OXA-181 Co-Producing K51-ST16 Carbapenem-Resistant Klebsiella pneumoniae: Study of Its Potential Dissemination Mediated by Conjugative Plasmids and Insertion Sequences.

Feilong Zhang, Ziyao Li, Xinmeng Liu, Guolan Luo, Yongli Wu, Chen Li, Jiankang Zhao, Yulin Zhang, Yanning Hu, Binghuai Lu

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Distribution of ST116 carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  2. Extensively Drug-Resistant ST16Infection and drug resistance · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Carbapenem-resistantFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Feilong ZhangPeking University China-Japan Friendship School of Clinical Medicine, Beijing, China.
Ziyao LiLaboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, National Center for Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Xinmeng LiuPeking University China-Japan Friendship School of Clinical Medicine, Beijing, China.
Guolan LuoDepartment of Laboratory Medicine, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Yongli WuLaboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, National Center for Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Chen LiPeking University China-Japan Friendship School of Clinical Medicine, Beijing, China.
Jiankang ZhaoLaboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, National Center for Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Yulin ZhangLaboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, National Center for Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Yanning HuPeking University China-Japan Friendship School of Clinical Medicine, Beijing, China.
Binghuai LuPeking University China-Japan Friendship School of Clinical Medicine, Beijing, China.ORCID 0000-0003-3510-2747
Chinese Academy of Medical Sciences & Peking Union Medical College · CNFourth Affiliated Hospital of Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The carbapenem-resistant Klebsiella pneumoniae (CRKP) strain GX34 was recovered from the respiratory tract of an elderly male with severe pneumonia, and only susceptible to amikacin, tigecycline, and colistin. Complete genome suggested that it belonged to K51-ST16 and harbored plasmid-encoded NDM-4 and OXA-181, located on IncFIB plasmid GX34p1_NDM-4 and ColKP3/IncX3 plasmid GX34p4_OXA-181, respectively. A series of transconjugants generated in the plasmid conjugation assays, including Escherichia coli J53-N1 (harboring a self-transmissible and

Indexed as

Carbapenem-Resistant EnterobacteriaceaeKlebsiella InfectionsAgedAnti-Bacterial Agentsbeta-LactamasesCarbapenemsDNA Transposable ElementsEscherichia coliHumansInterleukin-24Klebsiella pneumoniaeMaleMicrobial Sensitivity TestsPlasmidsAnti-Bacterial Agentsbeta-LactamasesCarbapenemsDNA Transposable ElementsInterleukin-24blaNDM-4blaOXA-181carbapenem-resistant Klebsiella pneumoniaehybrid plasmidIS26

Identifiers

PMID36602346
PMCPMC9872697
OpenAlexW4313544511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.